Journal of Hepatology
Volume 44, Issue 1 , Pages 39-46 , January 2006

Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan

  • Chun-Jen Liu

      Affiliations

    • Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
    • ,
  • Shyh-Chyi Lo

      Affiliations

    • Department of Laboratory Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
    • ,
  • Jia-Horng Kao

      Affiliations

    • Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
    • Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, 1 Chang-Te Street, Taipei 100, Taiwan
    • Hepatitis Research Center, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
    • ,
  • Ping-Tsung Tseng

      Affiliations

    • Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
    • ,
  • Ming-Yang Lai

      Affiliations

    • Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
    • Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, 1 Chang-Te Street, Taipei 100, Taiwan
    • ,
  • Yen-Hsuan Ni

      Affiliations

    • Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
    • ,
  • Shiou-Hwei Yeh

      Affiliations

    • Department of Microbiology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
    • ,
  • Pei-Jer Chen

      Affiliations

    • Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
    • Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, 1 Chang-Te Street, Taipei 100, Taiwan
    • Department of Medical Research, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
    • Corresponding Author InformationCorresponding author. Address: Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, 1 Chang-Te Street, Taipei 100, Taiwan. Tel.: 886 2 23123456x7072; fax: 886 2 23317624.
    • ,
  • Ding-Shinn Chen

      Affiliations

    • Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
    • Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, 1 Chang-Te Street, Taipei 100, Taiwan

Received 22 March 2005 ,Revised 6 June 2005 ,Accepted 17 June 2005.

References 

  1. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med. 1996;334:1685–1690
  2. Hoofnagle J. Posttransfusion hepatitis B. Transfusion. 1990;30:384–386
  3. Alter HJ, Holland PV, Purcell RH, Lander JJ, Feinstone SM, Morrow AG, et al. Post-transfusion hepatitis after exclusion of commercial and hepatitis-B antigen positive donors. Ann Intern Med. 1972;77:691–699
  4. Donahue JG, Munoz A, Ness PM, Brown DE, Yawn DH, McAllister HA, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med. 1992;327:369–373
  5. Busch MP. Prevention of hepatitis B, hepatitis C, and human immunodeficiency virus infection through blood transfusion by anti-HBc testing. Vox Sang. 1998;74:147–154
  6. Pillonel J, Laperche S. Groupe ‘Agents Transmissibles par Transfusion’ de la Societe francaise de transfusion sanguine; Etablissement francais du sang; Centre de transfusion sanguine des armees. Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992–2002 and impact of nucleic acid testing. Transf Clin Biol. 2004;11:81–86
  7. Busch MP, Kleinman SH, Nemo GJ. Current and emerging infectious risks of blood transfusions. JAMA. 2003;289:959–962
  8. Kleinman SH, Busch MP. The risk of transfusion-transmitted infection: direct estimation and mathematical modeling. Baillieres Best Pract Res Clin Haematol. 2000;13:631–649
  9. Wang JT, Wang TH, Sheu JC, Shih LN, Lin JT, Chen DS. Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen. J Infect Dis. 1991;163:397–399
  10. Kao JH, Chen PJ, Lai MY, Chen DS. Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C. J Clin Microbiol. 2002;40:4068–4071
  11. Noborg U, Gusdal A, Horal P, Lindh M. Levels of viraemia in subjects with serological markers of past or chronic hepatitis B virus infection. Scand J Infect Dis. 2000;32:249–252
  12. Shih LN, Sheu JC, Wang JT, Huang GT, Yang PM, Lee HS, et al. Serum hepatitis B virus DNA in healthy HBsAg-negative Chinese adults evaluated by polymerase chain reaction. J Med Virol. 1990;32:257–260
  13. Yotsuyanagi H, Yasuda K, Iino S, Moriya K, Shintani Y, Fujie H, et al. Persistent viremia after recovery from self-limited acute hepatitis B. Hepatology. 1998;27:1377–1382
  14. Matsumoto C, Tadokoro K, Fujimura K, Hirakawa S, Mitsunaga S, Juji T. Analysis of HBV infection after blood transfusion in Japan through investigation of a comprehensive donor specimen repository. Transfusion. 2001;41:878–884
  15. Prince AM, Lee DH, Brotman B. Infectivity of blood from PCR-positive, HBsAg-negative, anti-HBs-positive cases of resolved hepatitis B infection. Transfusion. 2001;41:329–332
  16. Allain JP, Hewitt PE, Tedder RS, Williamson LM. Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion. Br J Haematol. 1999;107:186–195
  17. Fang CT, Tobler LH, Haesche C, Busch MP, Phelps B, Leparc G. Fluctuation of HCV viral load before seroconversion in a healthy volunteer blood donor. Transfusion. 2003;43:541–544
  18. Sacher RA, Schreiber GB, Kleinman SH. Prevention of transfusion-transmitted hepatitis. Lancet. 2000;355:331–332
  19. Flanagan P, Barbara J. PCR testing of plasma pools: from concept to reality. Trans Med Rev. 1999;13:164–176
  20. Gallarda JJ, Dragon E. Blood screening by nucleic acid amplification technology: current issues, future challenges. Mol Diagn. 2000;5:11–21
  21. Rawal BD. Infectious HBV window period and its projected reduction by genome amplification testing. Transfusion 1998;38(suppl):91S.
  22. Schuttler CG, Caspari G, Jursch CA, Willems WR, Gerlich WH, Schaefer S. Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA. Lancet. 2000;355:41–42
  23. Sun R, Schilling W, Jayakar H, Ku J, Wang J, Rosenstraus M, et al. Simultaneous extraction of hepatitis C virus (HCV), hepatitis B virus, and HIV-1 from plasma and detection of HCV RNA by a reverse transcriptase-polymerase chain reaction assay designed for screening pooled units of donated blood. Transfusion. 1999;39:1111–1119
  24. Wang JT, Wang TH, Lin JT, Lee CZ, Sheu JC, Chen DS. Effect of hepatitis C antibody screening in blood donors on post-transfusion hepatitis in Taiwan. J Gastroenterol Hepatol. 1995;10:454–458
  25. Roth WK, Buhr S, Drosten C, Seifried E. NAT and viral safety in blood transfusion. Vox Sang. 2000;7878:257–259
  26. Stramer SL, Caglioti S, Strong DM. NAT of the United States and Canadian blood supply. Transfusion. 2000;40:1165–1168
  27. Chen DS. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science. 1993;262:369–370
  28. Chen DS. Natural history of chronic hepatitis B virus infection: new light on an old story. J Gastroenterol Hepatol. 1993;8:470–475
  29. Wang JT, Lee CZ, Chen PJ, Wang TH, Chen DS. Transfusion-transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carrier. Transfusion. 2002;42:1592–1597
  30. Lin YC, Chang MH, Ni YH, Hsu HY, Chen DS. Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. J Infect Dis. 2003;187:134–138
  31. Hsu HM, Lu CF, Lee SC, Lin SR, Chen DS. Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization. J Infect Dis. 1999;179:367–370
  32. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med. 1997;335:1855–1859
  33. Chen HL, Chang MH, Ni YH, Hsu HY, Lee PI, Lee CY, et al. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA. 1996;276:906–908
  34. Hsu HY, Chang MH, Ni YH, Chen HL. Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan. Gut. 2004;53:1499–1503
  35. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med. 2001;135:796–800
  36. Yeh SH, Tsai CY, Kao JH, Liu CJ, Kuo TJ, Lin MW, et al. Combined real-time PCR quantification and signature single nucleotide polymorphism genotyping of hepatitis B virus in one-tube reaction. J Hepatol. 2004;41:659–666
  37. Kwok S, Higuchi R. Avoid false positive with PCR. Nature. 1989;339:237–238
  38. Liu CJ, Kao JH, Chen PJ, Lai MY, Chen DS. Molecular epidemiology of hepatitis B viral serotypes and genotypes in Taiwan. J Biomed Sci. 2002;9:166–170
  39. Kao JH, Chen PJ, Lai MY, Chen DS. Sequence analysis of pre-s/surface and pre-core/core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection. J Med Virol. 2002;68:216–220
  40. Liu CJ, Kao JH, Shau WY, Chen PJ, Lai MY, Chen DS. Naturally occurring hepatitis B virus surface gene variants: Correlation with viral serotypes and clinical stages of liver disease. J Med Virol. 2002;68:50–59
  41. Mine H, Emura H, Miyamoto M, Tomono T, Minegishi K, Murokawa H, et al. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex regent in Japan. J Virol Methods. 2003;112:145–151
  42. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis. 2002;2:479–486
  43. Pereira A. Health and economic impact of posttransfusion hepatitis B and cost-effectiveness analysis of expanded HBV testing protocols of blood donors: a study focused on the European Union. Transfusion. 2003;43:192–201
  44. Marshall DA, Kleinman SH, Wong JB, AuBuchon JP, Grima DT, Kulin NA, et al. Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the Unites States. Vox Sang. 2004;86:28–40
  45. Goodman JL. The safety and availability of blood and tissues-progress and challenges. N Engl J Med. 2004;351:819–822
  46. Zou S, Dodd RY, Stramer SL, Strong DM, the Tissue Safety Study Group . Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the Unites States. N Engl J Med. 2004;351:751–759
  47. Stramer SL, Glynn SA, Kleinman SH, Strong DM, Sally C, Wright DJ, et al Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med. 2004;351:760–768
  48. Biswas R, Tabor E, Hsia CC, Wright DJ, Laycock ME, Fiebig EW, et al Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion. 2003;43:788–798

PII: S0168-8278(05)00449-6

doi: 10.1016/j.jhep.2005.06.016

Journal of Hepatology
Volume 44, Issue 1 , Pages 39-46 , January 2006

Article Tools

* Image Usage & Resolution